| First Author | Fujita K | Year | 2018 |
| Journal | eNeuro | Volume | 5 |
| Issue | 4 | PubMed ID | 30225354 |
| Mgi Jnum | J:271030 | Mgi Id | MGI:6274022 |
| Doi | 10.1523/ENEURO.0217-18.2018 | Citation | Fujita K, et al. (2018) Ser46-Phosphorylated MARCKS Is a Marker of Neurite Degeneration at the Pre-aggregation Stage in PD/DLB Pathology. eNeuro 5(4):ENEURO.0217-18.2018 |
| abstractText | Phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) reflects neurite degeneration at the early stage of Alzheimer's disease (AD), before extracellular Abeta aggregates are histologically detectable. Here, we demonstrate that similar changes in MARCKS occur in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) pathologies in both mouse models and human patients. The increase in the level of pSer46-MARCKS began before alpha-synuclein aggregate formation, at a time when human alpha-Syn-BAC-Tg/GBA-hetero-KO mice exhibited no symptoms, and was sustained during aging, consistent with the pattern in human postmortem brains. The results strongly imply a common mechanism of pre-aggregation neurite degeneration in AD and PD/DLB pathologies. |
